Literature DB >> 20920569

Evaluation of the disease modifying activity of Colchicum luteum Baker in experimental arthritis.

Vinod Nair1, Surender Singh, Y K Gupta.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Colchicum luteum (CL) has been traditionally used in the Unani system of medicine as a chief ingredient of many polyherbal formulations for the treatment of joint pain and rheumatoid arthritis (RA). AIM OF THE STUDY: To evaluate the antiarthritic activity of CL hydroalcoholic extract (CLHE) in formaldehyde and complete Freund's adjuvant (CFA) induced arthritis.
MATERIALS AND METHODS: Arthritis was induced by administration of either formaldehyde (2% v/v) or CFA into the subplantar surface of the hind paw of the animal. Joint swelling was measured on days 8, 9 and 10 in formaldehyde induced arthritis and days 3, 7, 14 and 21 in CFA induced arthritis. In order to evaluate the effect of CLHE on disease progression, serum TNF-α level and synovial expression of proinflammatory mediators (TNF-R1, IL-6 and IL-1β) was determined in CFA induced arthritis.
RESULTS: CLHE produced a significant and dose dependent inhibition of joint swelling during the entire duration of the study in both, formaldehyde and CFA induced arthritis. Serum TNF-α level was also reduced significantly in a dose dependent manner in all the CLHE treated groups. The expression of proinflammatory mediators (TNF-R1, IL-6 and IL-1β) was also found to be less in the CLHE treated group as compared to control.
CONCLUSION: We believe that the antiarthritic activity of CLHE was due to its modulatory effect on the expression of proinflammatory cytokine in the synovium. Our results contribute towards validation of the traditional use of CL in the treatment of RA and other inflammatory joint disorders. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20920569     DOI: 10.1016/j.jep.2010.09.027

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  8 in total

Review 1.  Potentially effective natural drugs in treatment for the most common rheumatic disorder: osteoarthritis.

Authors:  Mohammad Hosein Farzaei; Fatemeh Farzaei; Maziar Gooshe; Zahra Abbasabadi; Nima Rezaei; Amir Hossein Abdolghaffari
Journal:  Rheumatol Int       Date:  2014-11-15       Impact factor: 2.631

2.  Investigation into the anti-inflammatory and antigranuloma activity of Colchicum luteum Baker in experimental models.

Authors:  Vinod Nair; Rohit Kumar; Surender Singh; Y K Gupta
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

3.  Therapeutic effect of umbelliferon-α-D-glucopyranosyl-(2(I)→1(II))-α-D-glucopyranoside on adjuvant-induced arthritic rats.

Authors:  Vikas Kumar; Firoz Anwar; Amita Verma; Mohd Mujeeb
Journal:  J Food Sci Technol       Date:  2014-05-11       Impact factor: 2.701

4.  Antiarthritic effects of Ajuga bracteosa Wall ex Benth. in acute and chronic models of arthritis in albino rats.

Authors:  Gaurav Kaithwas; Raju Gautam; Sanjay M Jachak; Arvind Saklani
Journal:  Asian Pac J Trop Biomed       Date:  2012-03

5.  Investigation of antiarthritic potential of Plumeria alba L. leaves in acute and chronic models of arthritis.

Authors:  Manjusha Choudhary; Vipin Kumar; Pankaj Gupta; Surender Singh
Journal:  Biomed Res Int       Date:  2014-06-15       Impact factor: 3.411

6.  Anti-inflammatory and antiarthritic activity of UNIM-301 (a polyherbal unani formulation) in Wistar rats.

Authors:  Surender Singh; Rohit Kumar; Hitesh Jain; Y K Gupta
Journal:  Pharmacognosy Res       Date:  2015 Apr-Jun

7.  In vivo antiarthritic activity of Rosa centifolia L. flower extract.

Authors:  Rohit Kumar; Vinod Nair; Surender Singh; Yogendra Kumar Gupta
Journal:  Ayu       Date:  2015 Jul-Sep

8.  The Ethanolic Extract of Eysenhardtia polystachya (Ort.) Sarg. Bark and Its Fractions Delay the Progression of Rheumatoid Arthritis and Show Antinociceptive Activity in Murine Models.

Authors:  Saudy Saret Pablo-Pérez; Benjamín Parada-Cruz; Olivier Christophe Barbier; María Estela Meléndez-Camargo
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.